Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions that occurred between March 7 and 13. Deal Watch is supported by deal intelligence from Strategic Transactions.
Stuck between a rock and a hard place, troubled clinical-stage antibiotic firm Cempra Inc. has retained Morgan Stanley to...








